Fri, May 25, 2012
LONDON (Reuters) - European regulators confirmed on Friday that Roche's blockbuster cancer drug MabThera, also known as Rituxan, was safe to use, following a ...
Fri, May 25, 2012
LONDON (Reuters) - Doctors and patients should be given clearer guidance on how to avoid bleeding risks when using Boehringer Ingelheim's new stroke prevention ...
Thu, May 24, 2012
(Reuters) - A U.S. health advisory panel on Thursday issued a split vote on data for Pfizer Inc's drug to treat a rare ...
Thu, May 24, 2012
(Reuters) - U.S. generic drug maker Mylan Inc settled a patent infringement suit with Sunovion Pharmaceuticals Inc, a unit of Dainippon Sumitomo Pharma Co ...
Thu, May 24, 2012
By Anna Yukhananov
WASHINGTON (Reuters) - The U.S. Senate on Thursday showed near-unanimous support for a bill that helps fund the U.S. Food ...
Thu, May 24, 2012
(Reuters) - Biopharmaceutical company Theravance Inc said it licensed its technology to manufacture antibiotic Vibativ to specialty medicines maker Hospira Inc.
The company would purchase ...
Thu, May 24, 2012
By Andrew M. Seaman
NEW YORK (Reuters Health) - Doctors find a high number of malignant tumors when a state-wide skin cancer screening program is ...
Thu, May 24, 2012
By Lisa Baertlein
OAK BROOK, Ill., May 24 - McDonald's Corp investors soundly rejected a shareholder proposal that would have required the world's ...
Thu, May 24, 2012
By Amy Norton
NEW YORK (Reuters Health) - Soy-rich diets have been linked to lower rates of heart disease, but a small study suggests that ...
Thu, May 24, 2012
By Mike Collett
BUDAPEST (Reuters) - Howard Webb, the referee when Bolton Wanderers midfielder Fabrice Muamba collapsed on the pitch with a cardiac arrest and ...
Recent Comments